The simple, template free synthesis of a Bi2S3-ZnO heterostructure and its superior photocatalytic activity under UV-A light.
Subramanian Balachandran, Meenakshisundaram Swaminathan
Index: Dalton Trans. 42(15) , 5338-47, (2013)
Full Text: HTML
Abstract
The development of a heterostructured semiconductor photocatalyst makes a significant advancement in catalytic technologies. Highly crystalline Bi2S3-ZnO nanosheets with a hierarchical structure have been successfully synthesized by a facile sonochemical process and characterized by X-ray diffraction (XRD), high resolution scanning electron microscopy (HR-SEM), X-ray photoelectron spectroscopy (XPS), UV-Vis diffuse reflectance spectroscopy (DRS), photoluminescence spectroscopy (PL) and Brunauer-Emmett-Teller (BET) surface area measurements. X-ray powder diffraction (XRD) analysis reveals that the as synthesized product has an orthorhombic phase of Bi2S3 and a hexagonal wurtzite phase of ZnO. XPS analysis shows the presence of the elements Zn, O, Bi and S and their oxidation states. Bi2S3-ZnO has increased absorption in the UV region as well as in the visible region. This heterostructured nano catalyst has a higher photocatalytic activity for the degradation of Acid Black 1 (AB 1) under UV-A light than pure ZnO, Bi2S3 and commercial Degussa P25. The heterojunction in the Bi2S3-ZnO photocatalyst has led to low recombination rates of photoinduced electron-hole pairs and an enhanced photocatalytic activity. Bi2S3-ZnO is advantageous in AB 1 degradation because of its reusability and higher efficiency at neutral pH 7.
Related Compounds
Related Articles:
Bismuth nanoparticles integration into heavy metal electrochemical stripping sensor.
2015-08-01
[Electrophoresis , doi:10.1002/elps.201400609, (2015)]
Effect of irrigation with Tetraclean on bacterial leakage of obturated root canals.
2014-04-01
[N. Y. State Dent. J. 80(3) , 39-43, (2014)]
2015-01-01
[J. Nanobiotechnology 13 , 76, (2015)]
Hydrogen sulfide production from subgingival plaque samples.
2015-10-01
[Anaerobe 35 , 21-7, (2015)]
Diagnostic use of cerebral and extracerebral oxysterols.
2004-02-01
[Clin. Chem. Lab Med. 42(2) , 186-91, (2004)]